Artificial increase of LDL-cholesterol in patients with high levels of lipoprotein (a): Usefulness of Seeman's correction factor

被引：0
|
作者：
Bajo-Martinez, A [1 ]
Martin-Lazaro, J [1 ]
Bernal, E [1 ]
Fabregate, R [1 ]
Ugalde-Canitrot, A [1 ]
Calbacho, M [1 ]
Maties, M [1 ]
Saban-Ruiz, J [1 ]
机构：
[1] Hosp Ramon y Cajal, E-28034 Madrid, Spain
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2003年 / 23卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P350
引用
收藏
页码：A61 / A61
页数：1
相关论文
共 50 条
  • [31] Computational statistical modelling for parameters optimization of LDL-cholesterol levels in patients with type 2 diabetes
    Ahmad, Wan Muhamad Amir W.
    Ghazali, Farah Muna Mohamad
    Bin Shahzad, Hazik
    Adnan, Mohamad Nasarudin
    Aleng, Nor Azlida
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2024, 23 (02): : 498 - 506
  • [32] Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD
    Vilar-Gomez, Eduardo
    Gawrieh, Samer
    Liang, Tiebing
    McIntyre, Adam D.
    Hegele, Robert A.
    Chalasani, Naga
    JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (02) : 275 - 291
  • [33] Triglyceride levels predict coronary artery disease prevalence only in patients with low ldl-cholesterol
    Wanitschek, M.
    Suessenbacher, A.
    Doerler, J.
    Pachinger, O.
    Ulmer, H.
    Alber, H. F.
    EUROPEAN HEART JOURNAL, 2010, 31 : 646 - 647
  • [34] Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation
    Claire Cannet
    Andrea Pilotto
    Júlio César Rocha
    Hartmut Schäfer
    Manfred Spraul
    Daniela Berg
    Peter Nawroth
    Christian Kasperk
    Gwendolyn Gramer
    Dorothea Haas
    David Piel
    Stefan Kölker
    Georg Hoffmann
    Peter Freisinger
    Friedrich Trefz
    Orphanet Journal of Rare Diseases, 15
  • [35] LDL-cholesterol goals and changes in C reactive protein in high coronary risk patients
    Costa, J. A.
    Rodilla, E.
    Perez-Lahiguera, F.
    Miralles, A.
    Gonzalez, C.
    Pascual, J. M.
    REVISTA CLINICA ESPANOLA, 2009, 209 (09): : 415 - 423
  • [36] CHANGES IN LIPOPROTEIN(A), LDL-CHOLESTEROL AND APOLIPOPROTEIN-B IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH DEXTRAN SULFATE LDL-APHERESIS
    LASUNCION, MA
    TERUEL, JL
    ALVAREZ, JJ
    CARRERO, P
    ORTUNO, J
    GOMEZCORONADO, D
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (12) : 819 - 826
  • [37] Correlation Between Reductions in LDL-cholesterol, Apolipoprotein B, and Lipoprotein(a) with Mipomersen in FH and Other Hypercholesterolemic Patients at High Risk for Coronary Disease
    Santos, Raul D.
    Raal, Frederick J.
    CIRCULATION, 2012, 126 (21)
  • [38] Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation
    Cannet, Claire
    Pilotto, Andrea
    Rocha, Julio Cesar
    Schaefer, Hartmut
    Spraul, Manfred
    Berg, Daniela
    Nawroth, Peter
    Kasperk, Christian
    Gramer, Gwendolyn
    Haas, Dorothea
    Piel, David
    Koelker, Stefan
    Hoffmann, Georg
    Freisinger, Peter
    Trefz, Friedrich
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [39] Influence of lipoprotein(a) levels on the achievement of therapeutic low-density lipoprotein (LDL)-cholesterol targets in high cardiovascular risk patients. Significance of corrected LDL
    Arrobas, Teresa
    Barco, Antonio
    Angel Rico, Miguel
    de la Iglesia, Reyes
    Isabel Oribe, Ana
    Cruz, Carmen
    Fabiani, Fernando
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2010, 22 (01): : 7 - 14
  • [40] Effect of mipomersen on LDL-cholesterol in patients with severe LDLhypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study)
    Waldmann, Elisa
    Vogt, Anja
    Crispin, Alexander
    Altenhofer, Julia
    Riks, Ina
    Parhofer, Klaus G.
    ATHEROSCLEROSIS, 2017, 259 : 20 - 25
12345